Supplementary Material_Table.docx (21 kB)
Download file

Supplementary Material Table - Real-World Clinical Outcomes of Patients With Myelofibrosis Treated With Ruxolitinib: a Medical Record Review

Download (21 kB)
dataset
posted on 14.04.2022, 10:44 by Francesco Passamonti, Florian H. Heidel, Rohan C. Parikh, Mayank Ajmera, Derek Tang, Jose Alberto Nadal, Keith L. Davis, Pranav Abraham

Supplemental Table 1. Physician characteristics. 

Supplemental Table 2. Symptom characteristics and distribution at ruxolitinib initiation. 

Supplemental Table 3. Factors Associated with Risk of Survival Including Receipt of Subsequent MF Treatment


Funding

Bristol-Myers Squibb

History